If Allergan thought it could satisfy angry investors by splitting the CEO and chairman jobs after Brent Saunders leaves the company, it'll have to think again. Another prominent activist—John Chevedden—is joining forces with rebels at Appaloosa to push for an immediate split.
privacy policy | terms of use | contact us | advertise | pharma jobs | pharma blogs | facebook | twitter
Copyright © 2024,